Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-09 BIENAIME JEAN JACQUES Director Sale 10b5-1 −10,000 $98.19 $982K 425,162
2024-01-09 BIENAIME JEAN JACQUES Director Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 171,000
2024-01-08 MEIER RICHARD A Director Gift −3,000 112,547
2024-01-08 BIENAIME JEAN JACQUES Director Other acquisition 10b5-1 +50 $99.05 $5K 425,162
2023-12-27 Bodem Barbara W. Director Grant or award +2,180 2,180
2023-12-27 Enyedy Mark J Director Grant or award +2,180 2,180
2023-12-27 Countouriotis Athena Director Grant or award +2,180 2,180
2023-12-21 BIENAIME JEAN JACQUES Director Exercise or conversion 10b5-1 +10,000 $63.10 $631K 435,112
2023-12-21 BIENAIME JEAN JACQUES Director Sale 10b5-1 −10,000 $93.99 $940K 425,112
2023-12-21 BIENAIME JEAN JACQUES Director Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 181,000
2023-12-13 Davis George Eric EVP, Chief Legal Officer Sale 10b5-1 −13,764 $95.30 $1.3M 55,710
2023-12-01 BIENAIME JEAN JACQUES Director Grant or award +2,370 425,112
2023-12-01 Hardy Alexander Chief Executive Officer Grant or award +68,039 68,039
2023-12-01 Hardy Alexander Chief Executive Officer Grant or award +47,332 115,371
2023-12-01 Hardy Alexander Chief Executive Officer Grant or award · Stock Option (Right to Buy Common Stock) +150,529 150,529
2023-12-01 Guyer Charles Greg EVP, Chief Technical Officer Grant or award +11,840 52,014
2023-12-01 FUCHS HENRY J President, Worldwide R&D Grant or award +17,750 194,254
2023-10-31 Guyer Charles Greg EVP, Chief Technical Officer Grant or award +133 $69.23 $9K 40,174
2023-10-04 BIENAIME JEAN JACQUES Director Other acquisition +10 $85.57 $856 422,742
2023-08-16 Ajer Jeffrey Robert EVP, Chief Commercial Officer Sale 10b5-1 −5,000 $90.00 $450K 60,804

Page 12 of 23 · 450 trades